ASCO 2018

Area: Oncology

Location: Chicago, United States

Date: June 1 to June 5

Description:

American Society of Clinical Oncology.


Search in Scientific Content:
Date
Filters:
Molecular
10:07

Molecular evolution in breast cancer

Presenter: Lajos Pusztai
Oncology
Novelties
10:22

Novelties in melanoma treatment at ASCO 2018

Presenter: Paolo A. Ascierto
Oncology
Immunother
11:02

Immunotherapy in SCLC

Presenter: Taofeek Kunle Owonikoko
Oncology
PROPHECY t
5:39

PROPHECY trial: circulating tumor cell AR-V7 detection in mCRPC receiving abiraterone or enzalutamide

Presenter: Andrew J. Armstrong
Oncology
State of a
20:11

State of art NET treatment in 2018

Presenter: Nicola Fazio
Oncology
Cabozatini
4:51

Cabozatinib vs sunitinib in advanced RCC PROPHECY trial: circulating tumor cell AR-V7 detection in mCRPC receiving abiraterone or enzalutamide

Presenter: Ronald C. Chen
Oncology
Immunother
8:05

Immunotherapy in colorectal cancer

Presenter: Michael Overman
Oncology
How do I t
5:07

How do I treat early relapsed follicular lymphoma?

Presenter: Jonathan W. Friedberg
Oncology
Treating s
3:44

Treating sarcoma in elderly patients

Presenter: Mark Agulnik
Oncology
VALENTINO
3:13

VALENTINO study: panitumumab maintenance therapy in RAS WT metastatic colorectal cancer

Presenter: Filippo Pietrantonio
Oncology
Cabozantin
8:40

Cabozantinib alone or in combination with trastuzumab in breast cancer with brain metastases

Presenter: Jose Pablo Leone
Oncology
ALEX Study
8:31

ALEX Study: alectinib vs crizotinib in untreated advanced ALK+ NSCLC 23

Presenter: D. Ross Camidge
Oncology
Phase 2 st
6:20

Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma

Presenter: Luciano J. Costa
Oncology
Tepotinib
3:50

Tepotinib in patients with advanced NSCLC harboring MET exon 14-skipping mutations

Presenter: Enriqueta Felip
Oncology
KEYNOTE-00
2:53

KEYNOTE-001 trial: 4-year OS for patients with advanced NSCLC

Presenter: Enriqueta Felip
Oncology
Update on
3:54

Update on KEYNOTE-052: first-line pembrolizumab in cisplatin-ineligible advanced urothelial cancer

Presenter: Jacqueline Vuky
Oncology

ASH 2023

2023-12-09 - 2023-12-12
San Diego, United States

ESMO 2023

2023-10-20 - 2023-10-24
Madrid, Spain

ESMO Breast Cancer 2023

2023-05-11 - 2023-05-13
Berlin, Germany

EADO 2023

2023-04-20 - 2023-04-22
Rome, Italy

AACR 2023

2023-04-14 - 2023-04-19
Orlando, United States

SABCS 2022

2022-12-07 - 2022-12-10
Alcobendas, Afghanistan

ESMO 2022

2022-09-09 - 2022-09-13
Paris, France

ASCO 2022

2022-06-03 - 2022-06-07
Chicago, United States

International Summit of Lung Cancer

2022-05-08 - 2022-05-09
Rome, Italy